The role of TGF-β in wet AMD remains controversial however, as TGF-β exhibits both pro- and anti-angiogenic effects in AMD models depending on disease stage, dose, signalling pathway target, and animal model (Tosi et al., 2018; K. Wang et al., 2018c). Here, TGFB1 is linked to wet macular degeneration.